Clinical Trial Update: Empagliflozin to Prevent Post-Operative Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 trial update investigating empagliflozin to prevent post-operative atrial fibrillation following CABG.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cabg
• Post-operative Atrial Fibrillation

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Rajaie Cardiovascular Medical and Research Center | Conditions: Post-operative Atrial Fibrillation, CABG | Phase 3 | Status: UNKNOWN